Literature DB >> 7037074

Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia.

R Storb.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7037074     DOI： 10.1007/bf00320311

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  24 in total

1.  A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

Authors:  B M Camitta; E D Thomas; D G Nathan; R P Gale; K J Kopecky; J M Rappeport; G Santos; E C Gordon-Smith; R Storb
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

2.  Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells.

Authors:  R Storb; P L Weiden; H J Deeg; T C Graham; K Atkinson; S J Slichter; E D Thomas
Journal:  Blood       Date:  1979-08       Impact factor: 22.113

3.  Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia.

Authors:  R Storb
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

4.  Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

Authors:  P J Tutschka; W E Beschorner; A C Allison; W H Burns; G W Santos
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

5.  Cyclosporin-A: effect on marrow engraftment and graft-versus-host disease in dogs.

Authors:  H J Deeg; R Storb; P L Weiden; T Graham; K Atkinson; E D Thomas
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

6.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

7.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.

Authors:  R Storb; E D Thomas; P L Weiden; C D Buckner; R A Clift; A Fefer; L P Fernando; E R Giblett; B W Goodell; F L Johnson; K G Lerner; P E Neiman; J E Sanders
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

8.  Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients.

Authors:  R Parkman; J Rappeport; B Camitta; R H Levey; D G Nathan
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

9.  Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia.

Authors:  M M Bortin; R P Gale; A A Rimm
Journal:  JAMA       Date:  1981-03-20       Impact factor: 56.272

10.  Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.

Authors:  R P Witherspoon; R Storb; H D Ochs; N Fluornoy; K J Kopecky; K M Sullivan; J H Deeg; R Sosa; D R Noel; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-08       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.